← Back to Search

Educational Videos for Cancer Communication

N/A

Recruiting

Led By Rebecca Pentz, PhD

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 4 years

Awards & highlights

Study Summary

This trial looks at how patients & providers communicate about immunotherapy & how educational videos can improve patient understanding.

Who is the study for?

This trial is for patients and healthcare providers at the Winship Cancer Institute who may discuss immunotherapy. It's also open to any cancer patient interested in how educational videos can help understand immunotherapy.Check my eligibility

What is being tested?

The study looks at communication issues during discussions about immunotherapy between patients and providers. It aims to find out where patients learn about it, their understanding, how healthcare workers explain it, and if videos improve patient knowledge.See study design

What are the potential side effects?

Since this trial involves educational materials like videos and interviews rather than medical treatments, there are no direct physical side effects associated with participating.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 4 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 4 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Correct definition rates (pre- versus post-video)

Misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources

Provider and patient preferences for information to be communicated about immunotherapy

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: InterviewExperimental Treatment2 Interventions

Patients and providers undergo observation during a conversation about immunotherapy. Then participate in an interview over 20 minutes.

Group II: Aim 4 tests an educational videoExperimental Treatment1 Intervention

The participants watch a video and their comprehension is tested in a pre and post methodology

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,640 Previous Clinical Trials

2,560,532 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,672 Previous Clinical Trials

40,926,316 Total Patients Enrolled

1 Trials studying Blood Cancers

70 Patients Enrolled for Blood Cancers

Rebecca Pentz, PhDPrincipal InvestigatorEmory University Hospital/Winship Cancer Institute

1 Previous Clinical Trials

100 Total Patients Enrolled

Media Library

Interview Clinical Trial Eligibility Overview. Trial Name: NCT05873608 — N/A

Blood Cancers Research Study Groups: Interview, Aim 4 tests an educational video

Blood Cancers Clinical Trial 2023: Interview Highlights & Side Effects. Trial Name: NCT05873608 — N/A

Interview 2023 Treatment Timeline for Medical Study. Trial Name: NCT05873608 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial presently enrolling participants?

"Affirmative, the information hosted on clinicaltrials.gov affirms that this medical trial is presently recruiting applicants. Initially posted on October 6th 2016 and last amended on June 5th 2023, the research requires 125 participants from 2 distinct sites."

Answered by AI

What is the cap on participant numbers in this clinical experiment?

"Affirmative. According to the clinicaltrials.gov repository, this trial is presently recruiting subjects and was initially posted on October 6th 2016; it has been recently amended on June 5th 2023. 125 volunteers need to be recruited from two separate locations."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Communication Issues in Patient and Provider Discussions of Immunotherapy

Rebecca D. Pentz 2016. "Communication Issues in Patient and Provider Discussions of Immunotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05873608.